PubRank
Search
About
Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm (SLEGD)
Clinical Trial ID NCT02005809
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02005809
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.
Gastric Cancer
2000
8.85
2
Endoscopic mucosal resection for treatment of early gastric cancer.
Gut
2001
8.70
3
Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study.
Gastrointest Endosc
2009
4.76
4
Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection--an analysis of risk factors.
Endoscopy
2008
3.50
5
New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife.
Endoscopy
2001
3.20
6
A second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary: a retrospective analysis of postendoscopic submucosal dissection bleeding.
Gastrointest Endosc
2009
2.24
7
Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
Am J Gastroenterol
2007
2.10
8
Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions.
World J Gastroenterol
2010
1.35
9
Technical feasibility of endoscopic submucosal dissection of gastrointestinal epithelial neoplasms with a splash-needle.
Surg Laparosc Endosc Percutan Tech
2008
1.12
10
A new method of endoscopic mucosal resection of neoplastic lesions in the stomach: its technical features and results.
Hepatogastroenterology
1998
0.94
11
Risk factors for delayed postendoscopic mucosal resection hemorrhage in patients with gastric tumor.
Eur J Gastroenterol Hepatol
2007
0.89
12
Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry.
Dig Dis Sci
2005
0.83
Next 100